F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 250
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F91A6AEE0EEEN
Leaflet:

Download PDF Leaflet

F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile
Summary

F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company that provides biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its products include medicines to treat cancers, brain diseases, viral and bacterial infections, debilitating diseases, cardiovascular and metabolism diseases; point-of-care testing devices; analyzers; blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. The company has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Roche is headquartered in Basel, Switzerland.

F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment Deals By Type, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Region, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Market, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals Summary, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deal Details
Asset Purchase
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio
Genentech Acquires NanoPrint LM60 Microarrayer Platform From Arrayit
Venture Financing
Omicia Raises USD23 Million in Series B Financing Round
Cota Raises Funds through Venture Financing
Purigen Biosystems Raises USD18.2 Million in Series A Financing
Flatiron Health Raises USD175 Million in Series C Financing
mySugr Raises USD4.8 Million in Venture Financing
Curetis Raises USD18 Million in Extended Series B Venture Financing
GeneWeave Biosciences Raises USD12 Million in Series B Venture Financing
Curetis Raises US$16.3 Million In Series B Financing
MacuLogix Raises US$3.6 Million In Series A Financing
Foundation Medicine Raises US$56 Million In Series B Financing
GeneWeave Raises US$12 Million In Series A Financing Round
GeneWeave Biosciences Raises USD12 Million in Venrture Financing
Aria Diagnostics Secures US$52.7 Million In Series C Venture Financing
Curetis Secures Additional US$13.3 Million In Series A Venture Financing
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing
Foundation Medicine Raises US$10 Million In Venture Financing
Ambit Biosciences Secures US$30 Million In Series D-2 Financing
DVS Sciences Secures US$14.6 Million In Series A Venture Financing
mtm Labs Secures Additional US$9.7 Million In Series C Financing Round
GeneWeave Biosciences Raises USD0.15 Million in Venture Financing
Foundation Medicine Raises US$25 Million In Series A Financing Round
Partnerships
Ariosa Diagnostics Enters into Licensing Agreement with Labs
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio
Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test
Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical
Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology
Research Ventures & Licensing Enters Into Licensing Agreement With Ventana Medical Systems
Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems
Circadian Technologies Enters Into Licensing Agreement With Chugai Pharma
Genentech And Roche Enter Into Licensing Agreement With ForSight VISION4 For Sustained Delivery Lucentis
Aposense Enters Into An Agreement With Roche
Alere Enters Into Licensing Agreement With Roche Diagnostics
Roche Diagnostics Enters Into Licensing Agreement With Alere
Roche Enters Into Licensing Agreement With QIAGEN
Affymetrix Enters Into An Agreement With Signature Diagnostics
Biosearch Technologies Expands Licensing Agreement With Roche Molecular Systems
Foundation Medicine Enters into Agreement with AstraZeneca
Senseonics Enters into Distribution Agreement with F. Hoffmann-La Roche
Cellnovo Enters into Agreement with Roche Diagnostics
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems
Foundation Medicine Enters into Agreement with Mirati Therapeutics
IMS Health Enters into Agreement with Foundation Medicine
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics
AstraZeneca Enters into Co-Development Agreement with Roche
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics
Bioprocessing Tech Institute Enters Into Agreement with Roche to Develop Cancer Therapeutics
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
AUT University Forms Joint Venture with Roche Diagnostics
Ventana Medical Enters into Co-Development Agreement with MedImmune
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology
Ventana Extends Co-Development Agreement With Bayer Pharma
Foundation Medicine Expands Co-Development Agreement With Novartis
OraSure Technologies Terminates Collaboration With Roche Diagnostics
Ventana Medical Systems Enters Into Co-Development Agreement With Incyte For Companion Diagnostic Tests
Pacific Biosciences Enters Into Co-Development Agreement With Roche For In Vitro Diagnostic Products
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests
Ariosa Diagnostics Enters Into Agreement With Fleury For Harmony Prenatal Test
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products
Ventana Medical Systems And TGen Enter Into Agreement To Develop Cancer Diagnostic Markers
Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics
Roche Enters Into Co-Development Agreement With BioLamina For Cell Culture Systems
Ariosa Diagnostics Enters Into Distribution Agreement With The Doctors Laboratory For Harmony Prenatal Test
Epizyme, Eisai And Roche Enter Into Co-Development Agreement For Companion Diagnostic Test
Roche Enters Into Co-Development Agreement With Precision System Science For PCR Instrument
NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology
Foundation Medicine Extends Co-Development Agreement With Novartis
Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Sysmex Extends Distribution Agreement With Roche
Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Co-Development Agreement With Technoclone
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems
AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich
Roche Enters Into Technology Integration Agreement With Labcyte
Roche Diagnostics Enters Into Distribution Agreement With DexCom
Roche Diagnostics Enters Into Research And Development Agreement With DexCom
Roche Professional Diagnostics Terminates Distribution Agreement With Diagnostica Stago
Response Biomedical Terminates Distribution Agreement With Roche Diagnostics
Roche Enters Into Distribution Agreement With PerkinElmer
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences
Roche Enters Into Collaboration With Evotec
University of Geneva, Hopitaux Universitaires de Geneve, SIB And Roche Form Partnership
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck
Roche Enters Into Co-Development Agreement With Clovis Oncology
Roche Applied Science Enters Into Partnership With TIB MOLBIOL
Roche Applied Science Enters Into Co-Marketing Agreement With IT-IS Life Sciences
Lonza Enters Into Distribution Agreement With Roche Applied Science
Foundation Medicine Enters Into An Agreement With Novartis
Itamar Medical Signs Co-Development Agreement With F. Hoffmann-La Roche
Transgene Enters Into Collaboration With Ventana Medical Systems
QIAGEN Enters Into Distribution Agreement With Roche Molecular Systems
Clovis Oncology Enteres Into Co-Development Agreement With Ventana Medical Systems
Roche Molecular Systems Enters Into Research Agreement With Merck Sharp & Dohme
OraSure Technologies Enters Into An Agreement With Roche Diagnostics
Sonic Healthcare Enters into Licensing Agreement with Ariosa Diagnostics
Roche Enters into Licensing Agreement with Dalcor Pharma
Cepheid Terminates Licensing Agreement With Roche
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University
MBM ScienceBridge Enters Into Licensing Agreement With Roche
Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche
F. Hoffmann-La Roche Enters Into Licensing Agreement With Genzyme
AsymmetRx Enters Into Licensing Agreement With Ventana Medical
Equity Offering
Foundation Medicine Raises USD250 Million in Private Placement of Shares
Ariosa Diagnostics Withdraws IPO
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million
Foundation Medicine Completes IPO Of Shares For US$122 Million
Debt Offering
Roche Prices Public Offering of Bonds Due 2020 for USD600 Million
Roche Prices Public Offering of 0.875% Bonds Due 2025 for USD1.14 Billion
Roche Plans to Raise USD1.5 Billion in Public Offering of Bonds
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2024
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2021
Roche Plans to Raise USD850 Million in Public Offering of Notes
Roche Plans to Raise USD500 Million in Public Offering of Bonds
Roche Plans to Raise USD300 Million in Public Offering of Bonds
Asset Transactions
Roche Rumored To Sell Its Diabetes Device Unit
SynenTec To Acquire Cellavista Systems Business From Roche
Acquisition
Novartis Plans to Sell its Stake in F. Hoffmann-La Roche
Roche Acquires GeneWEAVE BioSciences for USD350 Million
Roche Acquires CAPP Medical
Roche Acquires Signature Diagnostics
Roche Acquires Ariosa Diagnostics
Roche Acquires Bina Technologies
F. Hoffmann-La Roche Completes Acquisition of Iquum for USD450 Million
Roche Diagnostics Acquires Genia for up to USD350 Million
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion
Roche Acquires Constitution Medical For US$220 Million
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company
Roche Terminates Plans To Acquire Illumina
Roche Completes Acquisition Of Verum Diagnostica For US$15 Million
Roche Completes Acquisition Of mtm Labs
Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For US$126.14 Million
Ventana Medical Systems Acquires BioImagene
Roche Holding Acquires Medingo From Elron Electronic Industries
F. Hoffmann-La Roche Ltd. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters
Jul 01, 2015: Roche lays foundation stone of new IT innovation centre in Kaiseraugst
Jan 19, 2015: Roche opens new Learning Center in Kaiseraugst
Financial Announcements
Jan 28, 2016: Roche reports strong results in 2015
Jul 23, 2015: Roche delivers strong performance in the first half of 2015
Apr 22, 2015: Roche reports strong sales growth in the first quarter of 2015
Jan 28, 2015: Roche delivers solid results in 2014
Corporate Communications
Jan 28, 2016: Changes to the Roche Corporate Executive Committee
May 08, 2015: Change in Roche Board of Directors
Legal and Regulatory
Jul 04, 2016: Infringement procedure against Roche – EMA update
Other Significant Developments
May 06, 2016: Roche Announces Direct Sales of Kapa Biosystems NGS Products in Canada
Sep 11, 2015: For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
Jul 19, 2015: Roche expands HIV Global Access Program to include infants in resource limited settings
Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

F. Hoffmann-La Roche Ltd., Medical Equipment, Key Facts, 2015
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals Summary, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment Deals By Type, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Region, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Deals By Market, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals Summary, 2010 to YTD 2016
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio
Genentech Acquires NanoPrint LM60 Microarrayer Platform From Arrayit
Omicia Raises USD23 Million in Series B Financing Round
Cota Raises Funds through Venture Financing
Purigen Biosystems Raises USD18.2 Million in Series A Financing
Flatiron Health Raises USD175 Million in Series C Financing
mySugr Raises USD4.8 Million in Venture Financing
Curetis Raises USD18 Million in Extended Series B Venture Financing
GeneWeave Biosciences Raises USD12 Million in Series B Venture Financing
Curetis Raises US$16.3 Million In Series B Financing
MacuLogix Raises US$3.6 Million In Series A Financing
Foundation Medicine Raises US$56 Million In Series B Financing
GeneWeave Raises US$12 Million In Series A Financing Round
GeneWeave Biosciences Raises USD12 Million in Venrture Financing
Aria Diagnostics Secures US$52.7 Million In Series C Venture Financing
Curetis Secures Additional US$13.3 Million In Series A Venture Financing
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing
Foundation Medicine Raises US$10 Million In Venture Financing
Ambit Biosciences Secures US$30 Million In Series D-2 Financing
DVS Sciences Secures US$14.6 Million In Series A Venture Financing
mtm Labs Secures Additional US$9.7 Million In Series C Financing Round
GeneWeave Biosciences Raises USD0.15 Million in Venture Financing
Foundation Medicine Raises US$25 Million In Series A Financing Round
Ariosa Diagnostics Enters into Licensing Agreement with Labs
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio
Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test
Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical
Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology
Research Ventures & Licensing Enters Into Licensing Agreement With Ventana Medical Systems
Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems
Circadian Technologies Enters Into Licensing Agreement With Chugai Pharma
Genentech And Roche Enter Into Licensing Agreement With ForSight VISION4 For Sustained Delivery Lucentis
Aposense Enters Into An Agreement With Roche
Alere Enters Into Licensing Agreement With Roche Diagnostics
Roche Diagnostics Enters Into Licensing Agreement With Alere
Roche Enters Into Licensing Agreement With QIAGEN
Affymetrix Enters Into An Agreement With Signature Diagnostics
Biosearch Technologies Expands Licensing Agreement With Roche Molecular Systems
Foundation Medicine Enters into Agreement with AstraZeneca
Senseonics Enters into Distribution Agreement with F. Hoffmann-La Roche
Cellnovo Enters into Agreement with Roche Diagnostics
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems
Foundation Medicine Enters into Agreement with Mirati Therapeutics
IMS Health Enters into Agreement with Foundation Medicine
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics
AstraZeneca Enters into Co-Development Agreement with Roche
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics
Bioprocessing Tech Institute Enters Into Agreement with Roche to Develop Cancer Therapeutics
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
AUT University Forms Joint Venture with Roche Diagnostics
Ventana Medical Enters into Co-Development Agreement with MedImmune
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology
Ventana Extends Co-Development Agreement With Bayer Pharma
Foundation Medicine Expands Co-Development Agreement With Novartis
OraSure Technologies Terminates Collaboration With Roche Diagnostics
Ventana Medical Systems Enters Into Co-Development Agreement With Incyte For Companion Diagnostic Tests
Pacific Biosciences Enters Into Co-Development Agreement With Roche For In Vitro Diagnostic Products
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests
Ariosa Diagnostics Enters Into Agreement With Fleury For Harmony Prenatal Test
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products
Ventana Medical Systems And TGen Enter Into Agreement To Develop Cancer Diagnostic Markers
Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics
Roche Enters Into Co-Development Agreement With BioLamina For Cell Culture Systems
Ariosa Diagnostics Enters Into Distribution Agreement With The Doctors Laboratory For Harmony Prenatal Test
Epizyme, Eisai And Roche Enter Into Co-Development Agreement For Companion Diagnostic Test
Roche Enters Into Co-Development Agreement With Precision System Science For PCR Instrument
NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology
Foundation Medicine Extends Co-Development Agreement With Novartis
Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Sysmex Extends Distribution Agreement With Roche
Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Co-Development Agreement With Technoclone
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems
AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich
Roche Enters Into Technology Integration Agreement With Labcyte
Roche Diagnostics Enters Into Distribution Agreement With DexCom
Roche Diagnostics Enters Into Research And Development Agreement With DexCom
Roche Professional Diagnostics Terminates Distribution Agreement With Diagnostica Stago
Response Biomedical Terminates Distribution Agreement With Roche Diagnostics
Roche Enters Into Distribution Agreement With PerkinElmer
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences
Roche Enters Into Collaboration With Evotec
University of Geneva, Hopitaux Universitaires de Geneve, SIB And Roche Form Partnership
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck
Roche Enters Into Co-Development Agreement With Clovis Oncology
Roche Applied Science Enters Into Partnership With TIB MOLBIOL
Roche Applied Science Enters Into Co-Marketing Agreement With IT-IS Life Sciences
Lonza Enters Into Distribution Agreement With Roche Applied Science
Foundation Medicine Enters Into An Agreement With Novartis
Itamar Medical Signs Co-Development Agreement With F. Hoffmann-La Roche
Transgene Enters Into Collaboration With Ventana Medical Systems
QIAGEN Enters Into Distribution Agreement With Roche Molecular Systems
Clovis Oncology Enteres Into Co-Development Agreement With Ventana Medical Systems
Roche Molecular Systems Enters Into Research Agreement With Merck Sharp & Dohme
OraSure Technologies Enters Into An Agreement With Roche Diagnostics
Sonic Healthcare Enters into Licensing Agreement with Ariosa Diagnostics
Roche Enters into Licensing Agreement with Dalcor Pharma
Cepheid Terminates Licensing Agreement With Roche
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University
MBM ScienceBridge Enters Into Licensing Agreement With Roche
Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche
F. Hoffmann-La Roche Enters Into Licensing Agreement With Genzyme
AsymmetRx Enters Into Licensing Agreement With Ventana Medical
Foundation Medicine Raises USD250 Million in Private Placement of Shares
Ariosa Diagnostics Withdraws IPO
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million
Foundation Medicine Completes IPO Of Shares For US$122 Million
Roche Prices Public Offering of Bonds Due 2020 for USD600 Million
Roche Prices Public Offering of 0.875% Bonds Due 2025 for USD1.14 Billion
Roche Plans to Raise USD1.5 Billion in Public Offering of Bonds
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2024
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2021
Roche Plans to Raise USD850 Million in Public Offering of Notes
Roche Plans to Raise USD500 Million in Public Offering of Bonds
Roche Plans to Raise USD300 Million in Public Offering of Bonds
Roche Rumored To Sell Its Diabetes Device Unit
SynenTec To Acquire Cellavista Systems Business From Roche
Novartis Plans to Sell its Stake in F. Hoffmann-La Roche
Roche Acquires GeneWEAVE BioSciences for USD350 Million
Roche Acquires CAPP Medical
Roche Acquires Signature Diagnostics
Roche Acquires Ariosa Diagnostics
Roche Acquires Bina Technologies
F. Hoffmann-La Roche Completes Acquisition of Iquum for USD450 Million
Roche Diagnostics Acquires Genia for up to USD350 Million
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion
Roche Acquires Constitution Medical For US$220 Million
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company
Roche Terminates Plans To Acquire Illumina
Roche Completes Acquisition Of Verum Diagnostica For US$15 Million
Roche Completes Acquisition Of mtm Labs
Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For US$126.14 Million
Ventana Medical Systems Acquires BioImagene
Roche Holding Acquires Medingo From Elron Electronic Industries
F. Hoffmann-La Roche Ltd., Key Competitors
F. Hoffmann-La Roche Ltd., Key Employees
F. Hoffmann-La Roche Ltd., Subsidiaries

LIST OF FIGURES

F. Hoffmann-La Roche Ltd., Medical Equipment, Deals by Type, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Region, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Market, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals by Type, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Region, 2010 to YTD 2016
F. Hoffmann-La Roche Ltd., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: